Tech Company Financing Transactions
Livionex Funding Round
Private investors participated in a $4 million Series A funding round for Livionex. The round was announced on 5/14/2019.
Transaction Overview
Company Name
Announced On
5/14/2019
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will be used to accelerate the growth of their technology that is advancing treatments for gum disease, cataracts, and herpes simplex virus.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
PO Box 320928
Los Gatos, CA 95032
USA
Los Gatos, CA 95032
USA
Phone
Website
Email Address
Not Recorded
Overview
Livionex Inc. was founded in 2009 by Stanford and Berkeley alums with the goal of enhancing the quality and longevity of human life. Headquartered in Los Gatos, CA, Livionex develops novel therapies for a variety of age-related chronic diseases affecting billions of people worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amit Goswamy
Browse more venture capital transactions:
Prev: 5/14/2019: ElevateBio venture capital transaction
Next: 5/14/2019: Webscale venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs